MARKET

ALVOW

ALVOW

Alvotech
NASDAQ
0.6499
0.00
0.00%
Opening 09:30 12/05 EST
OPEN
--
PREV CLOSE
0.6499
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
4.990
52 WEEK LOW
0.5699
MARKET CAP
--
P/E (TTM)
3.107
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ALVOW last week (1124-1128)?
Weekly Report · 4d ago
Alvotech SA Wins European Approval for AVT03, Biosimilar to Prolia and Xgeva
Reuters · 11/24 10:30
ALVOTECH ANNOUNCES APPROVAL OF AVT03, A BIOSIMILAR TO PROLIA® AND XGEVA® (DENOSUMAB) IN THE EUROPEAN ECONOMIC AREA
Reuters · 11/24 10:30
Weekly Report: what happened at ALVOW last week (1117-1121)?
Weekly Report · 11/24 09:47
Alvotech and Advanz Pharma Secure EC Approval for Gobivaz Biosimilar to Simponi
Reuters · 11/20 09:00
ALVOTECH AND ADVANZ PHARMA RECEIVE MARKETING APPROVAL ACROSS THE EUROPEAN ECONOMIC AREA FOR GOBIVAZ®, A FIRST-IN-MARKET BIOSIMILAR TO SIMPONI® (GOLIMUMAB)
Reuters · 11/20 09:00
Weekly Report: what happened at ALVOW last week (1110-1114)?
Weekly Report · 11/17 09:47
UK Court Backs Alvotech in Eylea Biosimilar Manufacturing Dispute
Reuters · 11/12 22:13
More
About ALVOW
Alvotech SA is a biotechnology company. The Company is focused on the development and manufacture of biosimilar medicines for patients globally. It is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). It has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.

Webull offers Alvotech SA stock information, including NASDAQ: ALVOW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALVOW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALVOW stock methods without spending real money on the virtual paper trading platform.